Literature DB >> 12601060

The role of Fas-FasL in the development and treatment of ischemic retinopathy.

Ramon Barreiro1, Ramin Schadlu, John Herndon, Henry J Kaplan, Thomas A Ferguson.   

Abstract

PURPOSE: Define a role for Fas-FasL in oxygen-induced retinopathy and explore the mechanism of pigment-epithelium-derived growth factor (PEDF) inhibition in this model.
METHODS: Seven-day-old mice C57BL/6J (B6), FasL-defective (B6-gld), or Fas-defective (B6-lpr) mice were exposed to 75% oxygen for 5 days (postnatal day [P]7-P12) and returned to room air. On day P17, vascular architecture was assessed microscopically after perfusion with FITC-dextran, and preretinal nuclei were quantified by PAS and hematoxylin staining. In some experiments, mice were treated intraperitoneally with PEDF. Vascular architecture and preretinal nuclei counts were compared with those in PBS-treated control animals.
RESULTS: Oxygen-induced retinopathy was significantly increased in FasL-defective gld mice compared with wild-type B6 animals. This was manifested by an increase in the number of microaneurysms, neovascular tufts, and preretinal nuclei. PEDF treatment prevented retinopathy in B6, B6-gld, and B6-lpr mice.
CONCLUSIONS: Fas-FasL interactions regulate the extent of oxygen-induced retinal neovascularization. The inhibition of neovascularization in B6 gld, and B6-lpr mice by PEDF suggests that Fas-FasL interactions are probably not the mechanism for inhibition in this model.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12601060     DOI: 10.1167/iovs.02-0478

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  14 in total

Review 1.  Endothelial cell apoptosis in angiogenesis and vessel regression.

Authors:  Emma C Watson; Zoe L Grant; Leigh Coultas
Journal:  Cell Mol Life Sci       Date:  2017-06-23       Impact factor: 9.261

2.  Age-dependent changes in FasL (CD95L) modulate macrophage function in a model of age-related macular degeneration.

Authors:  Hui Zhao; Jayeeta Roychoudhury; Teresa A Doggett; Rajendra S Apte; Thomas A Ferguson
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-08-07       Impact factor: 4.799

3.  Targeting immune privilege to prevent pathogenic neovascularization.

Authors:  Jayeeta Roychoudhury; John M Herndon; Jiyi Yin; Rajendra S Apte; Thomas A Ferguson
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-02-17       Impact factor: 4.799

4.  miR-30a-5p inhibition promotes interaction of Fas+ endothelial cells and FasL+ microglia to decrease pathological neovascularization and promote physiological angiogenesis.

Authors:  Salome Murinello; Yoshihiko Usui; Susumu Sakimoto; Maki Kitano; Edith Aguilar; H Maura Friedlander; Amelia Schricker; Carli Wittgrove; Yoshihiro Wakabayashi; Michael I Dorrell; Peter D Westenskow; Martin Friedlander
Journal:  Glia       Date:  2018-11-28       Impact factor: 7.452

Review 5.  Angiogenesis in eye disease: immunity gained or immunity lost?

Authors:  Thomas A Ferguson; Rajendra S Apte
Journal:  Semin Immunopathol       Date:  2008-02-23       Impact factor: 9.623

Review 6.  Role of the retinal vascular endothelial cell in ocular disease.

Authors:  Arpita S Bharadwaj; Binoy Appukuttan; Phillip A Wilmarth; Yuzhen Pan; Andrew J Stempel; Timothy J Chipps; Eric E Benedetti; David O Zamora; Dongseok Choi; Larry L David; Justine R Smith
Journal:  Prog Retin Eye Res       Date:  2012-09-11       Impact factor: 21.198

7.  Laminin receptor involvement in the anti-angiogenic activity of pigment epithelium-derived factor.

Authors:  Adrien Bernard; Jacqueline Gao-Li; Claudio-Areias Franco; Tahar Bouceba; Alexis Huet; Zhenlin Li
Journal:  J Biol Chem       Date:  2009-02-17       Impact factor: 5.157

8.  TRAIL-deficient mice exhibit delayed regression of retinal neovascularization.

Authors:  Kristin E Hubert; Michael H Davies; Andrew J Stempel; Thomas S Griffith; Michael R Powers
Journal:  Am J Pathol       Date:  2009-11-05       Impact factor: 4.307

9.  MCP-1 deficiency delays regression of pathologic retinal neovascularization in a model of ischemic retinopathy.

Authors:  Michael H Davies; Andrew J Stempel; Michael R Powers
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-05-16       Impact factor: 4.799

10.  PEDF - A Noninhibitory Serpin with Neurotrophic Activity.

Authors:  N I Minkevich; V M Lipkin; I A Kostanyan
Journal:  Acta Naturae       Date:  2010-07       Impact factor: 1.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.